Increase of bone marrow lymphocytes in systemic mastocytosis: Reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens

Journal of Clinical Pathology

Volumn 56, Issue 8, 2003, Pages 575-578

  Horny, H P ^a   Lange, K ^a   Sotlar, K ^b   Valent, P ^c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CD2 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CHYMASE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR; TRYPTASE;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW BIOPSY; CELL COUNT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOMA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE AGGREGATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MAST CELL; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; T LYMPHOCYTE;

B-LYMPHOCYTES; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MARROW EXAMINATION; DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MASTOCYTOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN-2; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES; TRYPTASES;

EID: 0042090516     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.8.575     Document Type: Article

References (16)

1. Valent P, Horny H-P, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25.
2. Metcalfe DD. Diagnosis and classification of mastocytosis: current status. J Invest Dermatol 1991;96:2S-4S.
3. Horny H-P, Kaiserling E. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br J Haematol 1988;69:449-55.
4. Yoo D, Lessin LS, Jensen WN. Bone marrow mast cells in lymphoproliferative disorders. Ann Intern Med 1978;88:753-7.
5. Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 1981;75:34-8.
6. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis AM, Gelfand DH, Sninsky JJ, et al, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:153-8.
7. Wang W, Kumar P, Schwarz M, et al. PCR amplification of 40 year-old paraffin-embedded tumour tissues: comparison of four different DNA extraction and purification methods. Int J Oncol 1994;5:453-7.
8. Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using PNA-mediated PCR-clamping and hybridization probes. Am J Pathol 2003;162:737-46.
9. Horny H-P, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985;16:808-14.
10. Horny H-P, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001;25:543-51.
11. Akin C, Jaffe ES, Raffeld M, et al. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. Am J Clin Pathol 2002;118:242-7.
12. Li WV, Kapadia SB, Sonmez-Alpan W, et al. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD568, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol 1996;9:982-8.
13. Horny H-P, Sillaber C, Menke D, et al. Diagnostic utility of staining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-40.
14. Escribano L, Orfao A, Villarrubia J, et al. Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathologic bone marrow samples. Anal Cell Pathol 1998;16:151-9
15. Akin C, Kirshenbaum AS, Semere T, et al. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol 2000;28:140-7.
16. Hongyo T, Li T, Syaifudin M, et al. Specific c-kit mutations in sinonasal natural killer/T cell lymphoma in China and Japan. Cancer Res 2000;60:2345-7.